Bala Venkataraman, Avego founder and managing partner (L), and Bruno Paquin, AtomVie CEO

Cana­di­an CD­MO se­cures more fund­ing to get its man­u­fac­tur­ing site up and run­ning

Atom­Vie Glob­al Ra­dio­phar­ma Inc, a Cana­di­an ra­dio­phar­ma­ceu­ti­cal con­tract man­u­fac­tur­er, has re­ceived ad­di­tion­al funds to get its man­u­fac­tur­ing fa­cil­i­ty up and run­ning.

The man­u­fac­tur­er an­nounced that it has raised an ad­di­tion­al 90 mil­lion Cana­di­an dol­lars ($66.9 mil­lion) in a “Tranche 2 Se­ries A round,” led by the health­care in­vest­ment firm Avego Man­age­ment. The com­pa­ny pre­vi­ous­ly an­nounced a $40 mil­lion Se­ries A round last year, which con­tributed to the con­struc­tion of a new 64,000-square-foot fa­cil­i­ty.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.